Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-701,128
Closed -$54.7M 152
2020
Q4
$54.7M Sell
701,128
-1,579,786
-69% -$121M 0.57% 46
2020
Q3
$181M Sell
2,280,914
-3,668
-0.2% -$287K 2.13% 14
2020
Q2
$169M Buy
2,284,582
+522,885
+30% +$39.4M 2.33% 14
2020
Q1
$129M Buy
1,761,697
+433,174
+33% +$34M 2.21% 17
2019
Q4
$115M Buy
+1,328,523
New +$109M 1.54% 28
2019
Q3
Sell
-1,398,969
Closed -$112M 135
2019
Q2
$112M Sell
1,398,969
-616,165
-31% -$47.2M 1.39% 29
2019
Q1
$160M Buy
+2,015,134
New +$151M 1.86% 23

Other funds holding MRK

Carmignac Gestion's MRK Position: Q1 2021 in Review

Carmignac Gestion sold out of Merck (MRK) in Q1 2021, closing a stake of 701,128 shares — an estimated $54.7M sold.

Carmignac Gestion first reported a position in MRK in Q1 2019 and held it in 7 quarters. The position peaked at $181M in Q3 2020. 2,687 funds tracked by Wall St. Rank hold MRK as of Q1 2021.

  • Carmignac Gestion reported no remaining Merck position as of Q1 2021 after selling out during the quarter.
  • Carmignac Gestion sold 701,128 Merck shares in Q1 2021, an estimated $54.7M.
  • Carmignac Gestion first reported a position in Merck in Q1 2019 and held it in 7 quarters.
  • Carmignac Gestion's Merck position peaked at $181M in Q3 2020.
  • 2,687 funds tracked by Wall St. Rank held Merck as of Q1 2021.

Based on Carmignac Gestion's 13F filing for Q1 2021, filed 14 May 2021.